Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Ben on +44 1494 818005 or Ben@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Ben Chadwick
Team Leader
Ben@zenopa.com
+44 1494 818005

Testimonials
My time working with Zenopa as a contractor has been fantastic! I had initial reservations about working as a contractor fearing that it could potentially lead to difficulties in having issues resolve...
Idris, 2011

Amgen honours passing of founding CEO

24 April 2012 00:00 in Pharmaceutical Company Product News


Amgen has paid tribute to its founding chief executive officer (CEO) George Rathmann following the news of his recent passing.

Mr Rathmann was recruited by company founder Bill Bowes to lead the fledgling business from 1980 to 1988, while he also acted as chairman of the board until 1990.

An award-winning industry expert, the business leader was praised by Amgen for his passion and charisma, as well as his role in attracting talent and investment for the company during its crucial early years.

A full-size sculpture of Mr Rathmann was dedicated on Amgen's campus in 2004, followed in 2005 by the creation of the annual George B Rathmann Award, an accolade presented to staff members who exemplify Amgen's standards of excellence.

Kevin Sharer, the current chairman and CEO of Amgen, said: "Bob Bradway, our next CEO, and I both share George's commitment to patients and conviction that being science-based is the best foundation for innovation in biotechnology."

The California-based company employs around 17,000 people worldwide and serves patients affected by cancer, kidney disease, rheumatoid arthritis, bone disease and other serious ailments.ADNFCR-8000103-ID-801347431-ADNFCR

Other news stories from 24/04/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd